An open-label, add-on, drug-drug interaction study to assess the effect of FYX-051 on the pharmacokinetics and safety of warfarin in Japanese healthy adult male
Phase 3
- Conditions
- Healthy adult male
- Registration Number
- JPRN-jRCT2080221293
- Lead Sponsor
- SANWA KAGAKU KENKYUSHO CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
Japanese healthy adult male
Exclusion Criteria
Patients with any disease
Subjects with any history of diseases that might affect the assessment in the study
Subjects expressing the CYP2C9*3 genotype
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetics and Safety
- Secondary Outcome Measures
Name Time Method